First safety test for new brain drug in people with liver issues
NCT ID NCT07457229
Summary
This early-stage study aims to understand how a potential new drug called radiprodil is processed by the body in people with different levels of liver impairment. The drug is being developed for certain genetic brain disorders. About 40 adults, some with liver problems and some healthy, will take a single dose and be closely monitored for six days to see how their bodies handle it and check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Epic Medical Research
RECRUITINGDeSoto, Texas, 75115, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Texas Liver Institute
RECRUITINGSan Antonio, Texas, 78215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.